Streetbeat News

Assets

LUCD

PAVM

Lucid Diagnostics reported a 33% sequential increase in Q4 EsoGuard revenue, reaching $1.04M. The company's cash and equivalents stood at $18.9 million as of December 31, 2023, down from $22.5 million the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 9:33 pm

ELF

e.l.f. Beauty (NYSE:ELF) has significantly outperformed the market over the past 5 years, with an annualized return of 79.95%, turning a $100 investment into $1,871.28. The company now has a market capitalization of $11.17 billion.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 9:30 pm

VRTX

Vertex Pharmaceuticals (NASDAQ:VRTX) has delivered an average annual return of 20.71% over the past 20 years, turning a $100 investment into $4,416.45 today. The company's market capitalization stands at $107.71 billion.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 9:30 pm

CENX

CLF

IE

NEM

The U.S. Department of Energy selected Century Aluminum (CENX) and Cleveland-Cliffs (CLF) for funding to support decarbonization and new facilities, aiming to bolster the U.S. economy and green energy transition. Newmont Corporation (NEM) plans to sell its Akyem gold mine in Ghana, with Citigroup (C) handling the sale, as part of a strategy to raise funds post-Newcrest Mining acquisition. Ivanhoe Electric (IE) secured a 60% stake in the Samapleu-Grata Nickel-Copper Project, indicating strong future prospects for copper concentrate production.

Portfolio Pulse from Austin DeNoce

March 25, 2024 | 9:18 pm

HUBB

Over the past 5 years, Hubbell (NYSE:HUBB) has outperformed the market with an annualized return of 28.49%, growing a $100 investment to $352.43. Hubbell's market capitalization stands at $22.15 billion.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 9:00 pm

MRNA

Over the past 5 years, Moderna (NASDAQ:MRNA) has significantly outperformed the market with an annualized return of 27.27%, averaging 40.24% annually. A $100 investment in MRNA 5 years ago would now be worth $561.44. Moderna's current market capitalization stands at $42.31 billion.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 9:00 pm

INTU

Benzinga's options scanner detected unusual options activity for Intuit (NASDAQ:INTU), with over 16 trades amounting to $1,132,096. The focus is on a price band between $600.0 and $900.0. Significant trades include both bearish and bullish sentiments, with the most activity around the $600 strike price. Intuit's stock is currently down -0.72% at $639.09, with neutral RSI indicators. The next earnings report is expected in 57 days.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 8:45 pm

MGM

MGM Resorts has announced a public offering of $750 million in aggregate principal amount of 6.500% senior notes due 2032, priced at par. The transaction is slated to close on April 9, 2024, pending customary closing conditions.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 8:38 pm

COIN

Dogwifhat (CRYPTO: WIF) surged 15%, challenging Floki Inu (CRYPTO: FLOKI) in valuation, with a notable increase in trading volumes and social activity. Investor Jake Gagain suggests Coinbase should list WIF, while MaxBecauseBTC, a financial market analyst, holds WIF as his largest meme coin investment, praising its performance. The upcoming Benzinga's Future of Digital Assets conference will discuss digital asset investments, highlighting the growing interest in meme coins like Dogwifhat.

Portfolio Pulse from Khyathi Dalal

March 25, 2024 | 8:36 pm

STRO

Sutro Biopharma reported a Fiscal Year 2023 Earnings Per Share (EPS) of $(1.78) and announced its cash position as of December 31 to be $333.7 million.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 8:33 pm